Alexandre Alessi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandre Alessi has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Pio-Abreu
Universidade de São Paulo, Brazil
3 shared publications - Andrei Carvalho Sposito
Department of Internal Medicine, School of Medical Sciences, State University of Campinas, Campinas, Brazil
3 shared publications - Andréa Araujo Brandão
Universidade do Estado do Rio de Janeiro, Brasil
3 shared publications - Angela Maria Geraldo Pierin
Universidade de São Paulo
3 shared publications - Antonio Carlos de Souza Spinelli
Cardiocentro, Brasil
3 shared publications - Audes Diógenes Magalhães Feitosa
Pronto Socorro Cardiológico de Pernambuco (PROCAPE), University of Pernambuco , Rua dos Palmares, s/n, Santo Amaro, Recife, PE CEP 50100-060
3 shared publications
Latest Publications
- Open Access
- 21 November 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (4)
Rara Apresentação de Anomalia Congênita Anatômica de Artérias Coronárias em Exame de Angiotomografia
Introdução A origem anômala das artérias coronárias representa um grupo heterogêneo de alterações na origem e trajeto destes vasos, variando desde as mais
- 21 November 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (4)
Open AccessRara Apresentação de Anomalia Congênita Anatômica de Artérias Coronárias em Exame de Angiotomografia
Introdução A origem anômala das artérias coronárias representa um grupo heterogêneo de alterações na origem e trajeto destes vasos, variando desde as mais
- Open Access
- 21 November 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (4)
Rare Presentation of an Anatomical Congenital Anomaly of the Coronary Arteries on Computed Tomography Angiography
Introduction Anomalous origin of the coronary arteries represents a heterogeneous group of alterations in the origin and course of these vessels, ranging
- 21 November 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (4)
Open AccessRare Presentation of an Anatomical Congenital Anomaly of the Coronary Arteries on Computed Tomography Angiography
Introduction Anomalous origin of the coronary arteries represents a heterogeneous group of alterations in the origin and course of these vessels, ranging
- Open Access
- 1 January 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (4)
Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023
Table of contents Updates and modifications to the Brazilian Guidelines for In-Office and Out-of-Office Blood Pressure Measurement 10 Part 1 – Blood pressure measurement 10 […] Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023 Table of contents Updates and modifications to the Brazilian Guidelines for In-Office and Out-of-Office Blood Pressure Measurement 10 Part 1 – Blood pressure measurement 10 […] Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023
- 1 January 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (4)
Open AccessBrazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023
Table of contents Updates and modifications to the Brazilian Guidelines for In-Office and Out-of-Office Blood Pressure Measurement 10 Part 1 – Blood pressure measurement 10 […] Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023 Table of contents Updates and modifications to the Brazilian Guidelines for In-Office and Out-of-Office Blood Pressure Measurement 10 Part 1 – Blood pressure measurement 10 […] Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023
- Open Access
- 1 January 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (4)
Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
Sumário Atualizações e Mudanças nas Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório 10 Parte 1 – Medidas da Pressão Arterial 10 […] Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023 Sumário Atualizações e Mudanças nas Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório 10 Parte 1 – Medidas da Pressão Arterial 10 […] Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
- 1 January 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (4)
Open AccessDiretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
Sumário Atualizações e Mudanças nas Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório 10 Parte 1 – Medidas da Pressão Arterial 10 […] Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023 Sumário Atualizações e Mudanças nas Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório 10 Parte 1 – Medidas da Pressão Arterial 10 […] Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
- Top Cited PapersOpen Access
- 3 March 2021
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 116 (3) , 516-658
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Sumário 1. Definição, Epidemiologia e Prevenção Primária 528 1.1 Definição de Hipertensão Arterial 528 […] Diretrizes Brasileiras de Hipertensão Arterial – 2020 Sumário 1. Definição, Epidemiologia e Prevenção Primária 528 1.1 Definição de Hipertensão Arterial 528 […] Diretrizes Brasileiras de Hipertensão Arterial – 2020
- 3 March 2021
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 116 (3) , 516-658
Top Cited PapersOpen AccessDiretrizes Brasileiras de Hipertensão Arterial – 2020
Sumário 1. Definição, Epidemiologia e Prevenção Primária 528 1.1 Definição de Hipertensão Arterial 528 […] Diretrizes Brasileiras de Hipertensão Arterial – 2020 Sumário 1. Definição, Epidemiologia e Prevenção Primária 528 1.1 Definição de Hipertensão Arterial 528 […] Diretrizes Brasileiras de Hipertensão Arterial – 2020
- Open Access
- 16 October 2008
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 6 (1) , 52
Appropriateness of carotid plaque and intima-media thickness assessment in routine clinical practice
To describe the findings and evaluate appropriateness of a carotid artery study including the measurement of IMT, the presence of atherosclerotic plaque, and their correlation with cardiovascular risk factors. 555 patients (220 men; 67.06 +/- 12.44 years) were included in the study. 120 patients (21.62%) presented carotid plaque: 108 (19.45%) in patients with at least one risk factor and 12 (2.1%) in patients without risk factors. With respect to appropriateness of the present studies: 65% were appropriate, 22% were uncertain and 13% were inappropriate. The IMT medians were higher in males (0.0280; 95% CI, 00.82 to 0.478; p = 0.0057) and in hypertensive patients (0.391; 95% CI, 0.0190 to 0.0592; p = 0,001). There was a linear increase in mean IMT for each year increased in age (0.0059; 95% CI; 0.0050 to 0.0067). Carotid plaque was more frequent in patients with CAD (p = 0.0002), diabetes (p = 0.024) and hypertension (p = 0.036). Assessment of carotid arteries identified increased incidence of plaque in patients with CAD, diabetes and hypertension. IMT was increased in older patients, hypertensive patients and males. Forty-five percent of the patients were studied based on uncertain and inappropriate reasons.
- 16 October 2008
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 6 (1) , 52
Open AccessAppropriateness of carotid plaque and intima-media thickness assessment in routine clinical practice
To describe the findings and evaluate appropriateness of a carotid artery study including the measurement of IMT, the presence of atherosclerotic plaque, and their correlation with cardiovascular risk factors. 555 patients (220 men; 67.06 +/- 12.44 years) were included in the study. 120 patients (21.62%) presented carotid plaque: 108 (19.45%) in patients with at least one risk factor and 12 (2.1%) in patients without risk factors. With respect to appropriateness of the present studies: 65% were appropriate, 22% were uncertain and 13% were inappropriate. The IMT medians were higher in males (0.0280; 95% CI, 00.82 to 0.478; p = 0.0057) and in hypertensive patients (0.391; 95% CI, 0.0190 to 0.0592; p = 0,001). There was a linear increase in mean IMT for each year increased in age (0.0059; 95% CI; 0.0050 to 0.0067). Carotid plaque was more frequent in patients with CAD (p = 0.0002), diabetes (p = 0.024) and hypertension (p = 0.036). Assessment of carotid arteries identified increased incidence of plaque in patients with CAD, diabetes and hypertension. IMT was increased in older patients, hypertensive patients and males. Forty-five percent of the patients were studied based on uncertain and inappropriate reasons.
- Open Access
- 27 August 2008
- Published by Springer Nature in Thrombosis Journal
- Vol. 6 (1) , 12
Use of rosiglitazone before and after vascular injury in hypercholesterolemic rabbits: Assessment of neointimal formation
Objectives: To analyse the effects of rosiglitazone administered at different times on neointimal formation in hypercholesterolemic rabbits following vascular injury. Methods: Thirty-nine rabbits on a hypercholesterolemic diet were included. The animals underwent balloon catheter injury to the right iliac artery on day 14. They were divided into three groups as follows: control group, 13 rabbits without rosiglitazone; group I, 13 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) for 28 days after the vascular injury; and group II, 13 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) during all the experiment (42 days). Histological analysis was done by an experienced pathologist who was unaware of the rosiglitazone treatment. Histomorphometric parameters were performed by calculation of the luminal and intimal layer area, and intima/media layer area ratio (the area of the intimal layer divided by the area of the medial layer). Results: Intimal area was significantly lower in group II vs. CG (p = 0.024) and group I (p = 0.006). Luminal layer area was higher in group II vs. CG (p < 0.0001) and group I (p < 0.0001). Intima/media layer area ratio was equal between CG and group I. Intima/media layer ratio area was significantly lower in group II vs. control group (p < 0.021) and group I (p < 0.003). There was a significant reduction of 65% and 71% in intima/media layer area ratio in group II vs. control group and group I, respectively. Conclusion: Pretreatment with rosiglitazone in hypercholesterolemic rabbits submitted to vascular injury significantly reduces neointimal formation.
- 27 August 2008
- Published by Springer Nature in Thrombosis Journal
- Vol. 6 (1) , 12
Open AccessUse of rosiglitazone before and after vascular injury in hypercholesterolemic rabbits: Assessment of neointimal formation
Objectives: To analyse the effects of rosiglitazone administered at different times on neointimal formation in hypercholesterolemic rabbits following vascular injury. Methods: Thirty-nine rabbits on a hypercholesterolemic diet were included. The animals underwent balloon catheter injury to the right iliac artery on day 14. They were divided into three groups as follows: control group, 13 rabbits without rosiglitazone; group I, 13 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) for 28 days after the vascular injury; and group II, 13 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) during all the experiment (42 days). Histological analysis was done by an experienced pathologist who was unaware of the rosiglitazone treatment. Histomorphometric parameters were performed by calculation of the luminal and intimal layer area, and intima/media layer area ratio (the area of the intimal layer divided by the area of the medial layer). Results: Intimal area was significantly lower in group II vs. CG (p = 0.024) and group I (p = 0.006). Luminal layer area was higher in group II vs. CG (p < 0.0001) and group I (p < 0.0001). Intima/media layer area ratio was equal between CG and group I. Intima/media layer ratio area was significantly lower in group II vs. control group (p < 0.021) and group I (p < 0.003). There was a significant reduction of 65% and 71% in intima/media layer area ratio in group II vs. control group and group I, respectively. Conclusion: Pretreatment with rosiglitazone in hypercholesterolemic rabbits submitted to vascular injury significantly reduces neointimal formation.
- Open Access
- 16 May 2008
- Published by Springer Nature in Thrombosis Journal
- Vol. 6 (1) , 4
Effects of rosiglitazone on contralateral iliac artery after vascular injury in hypercholesterolemic rabbits
Background: The objective was to evaluate the effects of rosiglitazone on iliac arteries of hypercholesterolemic rabbits undergoing balloon catheter injury in the contralateral iliac arteries. Methods: White male rabbits were fed a hypercholesterolemic diet for 6 weeks and divided into two groups as follows: rosiglitazone group, 14 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) during 6 weeks; and control group, 18 rabbits without rosiglitazone treatment. All animals underwent balloon catheter injury of the right iliac artery on the fourteenth day of the experiment. Results: There was no significant difference in intima/media layer area ratio between the control group and the rosiglitazone group. Rosiglitazone did not reduce the probability of lesions types I, II, or III (72.73% vs. 92.31%; p = 0.30) and types IV or V (27.27% vs. 7.69%; p = 0.30). There were no differences in the extent of collagen type I and III deposition or in the percentage of animals with macrophages in the intima layer. The percentage of rabbits with smooth muscle cells in the intima layer was higher in rosiglitazone group (p = 0.011). Conclusion: These findings demonstrate that rosiglitazone given for 6 weeks did not prevent atherogenesis at a vessel distant from the injury site.
- 16 May 2008
- Published by Springer Nature in Thrombosis Journal
- Vol. 6 (1) , 4
Open AccessEffects of rosiglitazone on contralateral iliac artery after vascular injury in hypercholesterolemic rabbits
Background: The objective was to evaluate the effects of rosiglitazone on iliac arteries of hypercholesterolemic rabbits undergoing balloon catheter injury in the contralateral iliac arteries. Methods: White male rabbits were fed a hypercholesterolemic diet for 6 weeks and divided into two groups as follows: rosiglitazone group, 14 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) during 6 weeks; and control group, 18 rabbits without rosiglitazone treatment. All animals underwent balloon catheter injury of the right iliac artery on the fourteenth day of the experiment. Results: There was no significant difference in intima/media layer area ratio between the control group and the rosiglitazone group. Rosiglitazone did not reduce the probability of lesions types I, II, or III (72.73% vs. 92.31%; p = 0.30) and types IV or V (27.27% vs. 7.69%; p = 0.30). There were no differences in the extent of collagen type I and III deposition or in the percentage of animals with macrophages in the intima layer. The percentage of rabbits with smooth muscle cells in the intima layer was higher in rosiglitazone group (p = 0.011). Conclusion: These findings demonstrate that rosiglitazone given for 6 weeks did not prevent atherogenesis at a vessel distant from the injury site.
- Open Access
- 1 February 2002
- Published by FapUNIFESP (SciELO) in Arquivos Brasileiros de Cardiologia
- Vol. 78 (2) , 218-223
Influence of Quality of Sleep on the Nocturnal Decline in Blood Pressure During Ambulatory Blood Pressure Monitoring
OBJECTIVE: To assess the influence of the quality of sleep on the nocturnal physiological drop in blood pressure during ambulatory blood pressure monitoring. METHODS: We consecutively assessed ambulatory blood pressure monitoring, the degree of tolerance for the examination, and the quality of sleep in 168 patients with hypertension or with the suspected "white-coat" effect. Blood pressure fall during sleep associated with a specific questionnaire and an analogical visual scale of tolerance for ambulatory blood pressure monitoring were used to assess usual sleep and sleep on the day of examination. Two specialists in sleep disturbances classified the patients into 2 groups: those with normal sleep and those with abnormal sleep. RESULTS: Fifty-nine (35 %) patients comprised the abnormal sleep group. Findings regarding the quality of sleep on the day of ambulatory blood pressure monitoring as compared with those regarding the quality of sleep on a usual day were different and were as follows, respectively: total duration of sleep (-12.4±4.7 versus -42.2±14.9 minutes, P=0.02), latency of sleep (0.4±2.7 versus 17±5.1 minutes, P<0.001), number of awakenings (0.1±0.1 versus 1.35±0.3 times, P<0.001), and tolerance for ambulatory blood pressure monitoring (8±0.2 versus 6.7±0.35, P=0.035). An abnormal drop in blood pressure during sleep occurred in 20 (18%) patients in the normal sleep group and in 14 (24%) patients in the abnormal sleep group, P=0.53. CONCLUSION: Ambulatory blood pressure monitoring causes sleep disturbances in some patients, and a positive association between quality of sleep and tolerance for the examination was observed.
- 1 February 2002
- Published by FapUNIFESP (SciELO) in Arquivos Brasileiros de Cardiologia
- Vol. 78 (2) , 218-223
Open AccessInfluence of Quality of Sleep on the Nocturnal Decline in Blood Pressure During Ambulatory Blood Pressure Monitoring
OBJECTIVE: To assess the influence of the quality of sleep on the nocturnal physiological drop in blood pressure during ambulatory blood pressure monitoring. METHODS: We consecutively assessed ambulatory blood pressure monitoring, the degree of tolerance for the examination, and the quality of sleep in 168 patients with hypertension or with the suspected "white-coat" effect. Blood pressure fall during sleep associated with a specific questionnaire and an analogical visual scale of tolerance for ambulatory blood pressure monitoring were used to assess usual sleep and sleep on the day of examination. Two specialists in sleep disturbances classified the patients into 2 groups: those with normal sleep and those with abnormal sleep. RESULTS: Fifty-nine (35 %) patients comprised the abnormal sleep group. Findings regarding the quality of sleep on the day of ambulatory blood pressure monitoring as compared with those regarding the quality of sleep on a usual day were different and were as follows, respectively: total duration of sleep (-12.4±4.7 versus -42.2±14.9 minutes, P=0.02), latency of sleep (0.4±2.7 versus 17±5.1 minutes, P<0.001), number of awakenings (0.1±0.1 versus 1.35±0.3 times, P<0.001), and tolerance for ambulatory blood pressure monitoring (8±0.2 versus 6.7±0.35, P=0.035). An abnormal drop in blood pressure during sleep occurred in 20 (18%) patients in the normal sleep group and in 14 (24%) patients in the abnormal sleep group, P=0.53. CONCLUSION: Ambulatory blood pressure monitoring causes sleep disturbances in some patients, and a positive association between quality of sleep and tolerance for the examination was observed.